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Background: GDP-fucose and other sugar nucleotide biosynthetic pathways are conserved in the P. falciparum genome.
Results: These pathways are active in the intraerythrocytic life cycle of the parasite.
Conclusion:The parasite biosynthesizes GDP-fucose and other sugar nucleotides not related to the glycosylphosphatidylinosi-
tol structures
Significance: Their presence strongly suggests that they are involved in the biosynthesis of glycans not yet characterized.
Carbohydrate structures play important roles inmany biolog-
ical processes, including cell adhesion, cell-cell communication,
and host-pathogen interactions. Sugar nucleotides are activated
forms of sugars used by the cell as donors formost glycosylation
reactions. Using a liquid chromatography-tandem mass spec-
trometry-based method, we identified and quantified the pools
of UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine,
GDP-mannose, and GDP-fucose in Plasmodium falciparum
intraerythrocytic life stages. We assembled these data with the
in silico functional reconstruction of the parasite metabolic
pathways obtained from the P. falciparum annotated genome,
exposing new active biosynthetic routes crucial for further gly-
cosylation reactions. Fucose is a sugar present in glycoconju-
gates often associated with recognition and adhesion events.
Thus, the GDP-fucose precursor is essential in a wide variety of
organisms. P. falciparum presents homologues of GDP-man-
nose 4,6-dehydratase and GDP-L-fucose synthase enzymes that
are active in vitro, indicating thatmostGDP-fucose is formed by
a de novo pathway that involves the bioconversion of GDP-man-
nose. Homologues for enzymes involved in a fucose salvage
pathway are apparently absent in the P. falciparum genome.
This is in agreementwith in vivometabolic labeling experiments
showing that fucose is not significantly incorporated by the par-
asite. Fluorescence microscopy of epitope-tagged versions of
P. falciparum GDP-mannose 4,6-dehydratase and GDP-L-fu-
cose synthase expressed in transgenic 3D7 parasites shows that
these enzymes localize in the cytoplasm of P. falciparum during
the intraerythrocytic developmental cycle. Although the func-
tion of fucose in the parasite is not known, the presence of GDP-
fucose suggests that themetabolitemaybeused for further fuco-
sylation reactions.
Malaria is a global health problem caused by protozoan par-
asites of the genus Plasmodium and transmitted by the Anoph-
elesmosquito. Approximately half of the world’s population is
at risk of infection, and there are around 200 million cases
annually, leading to more than half a million deaths each year
(1). Most of the people who die are children living in resource-
poor countries in sub-Saharan Africa. Among the five Plasmo-
dium species that cause malaria in humans (Plasmodium
falciparum, Plasmodium vivax, Plasmodium malariae, Plas-
modium ovale, and Plasmodium knowlesi), P. falciparum is the
most deadly and is responsible for the majority of the malaria-
linked deaths in sub-Saharan Africa (1). Chemotherapy is one
of the central strategies for malaria treatment, but unfortu-
nately, drug resistance to commonly used antimalarial drugs
has spread very rapidly (2, 3). The implementation of new
approaches to prevent and fight malaria has greatly benefited
from the sequencing of the parasite genome (4) and the devel-
opment of improved tools for functional genomics (5–8). How-
ever, this area of research remains greatly limited by our incom-
plete knowledge of parasite biology (9). Therefore, it is critical
to promote research efforts that probe the basic biochemistry
and cell biology of Plasmodium with the aim of characterizing
essential proteins, metabolic pathways, and other processes
that could be suitable for intervention and to validate new can-
didate drug targets.
Glycosylphosphatidylinositol (GPI)4 anchors (10) represent
the major carbohydrate modification described in P. falcipa-
rum cell surface proteins (11). Several of these GPI-anchored
glycoproteins are essential for parasite invasion and virulence
(12), and GPI anchors are generated via a complex synthetic
pathway (13). Recently, Bushkin et al. (14) presented new evi-
dence demonstrating the existence of functional N-glycosyla-
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tion in the intraerythrocytic stages of P. falciparum. In general,
protozoan parasite N-glycosylation patterns are atypical of
those described in higher eukaryotes (15, 16). In P. falciparum,
the secondary loss of enzymes related to the biosynthesis of
N-glycosylation precursors and the quality control of glycopro-
tein folding in the endoplasmic reticulum (17, 18) result in a
very unusual N-glycosylation (14) that, if essential, could be
therapeutically exploitable. To our knowledge, despite some
controversy (19–24),O-glycans have never been unequivocally
described in P. falciparum. Thus, although there have been sig-
nificant efforts to understand the glycobiology of the parasite,
several questions on this topic remain unanswered.
Sugar nucleotides, the essential intermediates in carbohy-
drate metabolism and glycoconjugate biosynthesis, are acti-
vated forms of sugars produced by the cell as donor precursors
for most of the glycosylation reactions. They are formed in two
main ways: by a salvage pathway involving “activation” of the
sugar using a kinase and a pyrophosphorylase or by a de novo
pathway involving the bioconversion of an existing sugar or
sugar nucleotide. Specific P. falciparum metabolic databases
(25), based on the parasite genome sequence, predict the con-
servation of the de novo biosynthetic pathways for UDP-N-
acetyl-glucosamine, GDP-mannose, GDP-fucose, and UDP-
glucose.Most of the predicted open reading frames (ORFs) that
encode for the enzymes involved in these pathways are also
present in other Plasmodium species (P. vivax, P. knowlesi,
Plasmodium chabaudi, Plasmodium yoelii, and Plasmodium
berghei) (26), suggesting that they are conserved and encode for
proteins playing important roles in the parasite. Indeed, UDP-
N-acetyl-glucosamine and GDP-mannose (through its product
dolichol-phosphomannose) are essential donor substrates for
the biosynthesis of GPI structures (27). Because sugar nucleo-
tides are the “basic building blocks” of glycoconjugates, the con-
servation of their biosynthetic metabolic routes strongly sug-
gests the existence of further downstream glycosylation
reactions in which these metabolites are involved (i.e. glycan
biosynthesis).
In this work, we identify and quantify the sugar nucleotides
present in different stages of the intraerythrocytic life cycle of
P. falciparum using a liquid chromatography-tandem mass
spectrometry (LC-MS/MS)-based assay, and we present the
results in the context of the functional metabolic pathways
reconstructed from the genome of the parasite. We demon-
strate that P. falciparum is unable to take up significant
amounts of tritiated fucose from the culture media. Further-
more, we show that the putative GDP-fucose biosynthesis
enzymes are functional in vitro, by expressing them and detect-
ing GDP-fucose production. Endogenous forms of these
enzymes localize to the cytosol of P. falciparum. We show that
the genes encoding these enzymes are expressed at low abun-
dance, and their levels are modulated throughout the red blood
cell stages of the parasite. Finally, we also demonstrate that the
parasite expresses a protein o-fucosyltransferase homolog, and
schizont extracts incorporate tritiated GDP-fucose.
EXPERIMENTAL PROCEDURES
Parasites and Parasite Culture—P. falciparum 3D7
(obtained from MR4-ATCC) parasites were cultured with
human erythrocytes (3–4% hematocrit) in RPMI medium
(Sigma) supplemented with 10%AB human serum, incubated
at 37 °C in an atmosphere of 92% N2, 3% O2, and 5% CO2 using
standardmethods (28). For sugar nucleotide analysis and label-
ing experiments, parasites were grown in RPMI medium sup-
plemented with 0.5% Albumax II (Invitrogen) to avoid possible
variations due to the uses of different human serum batches.
Parasite growth was monitored by counting the infected eryth-
rocytes in Giemsa-stained thin blood smears under light
microscopy.
Sugar Nucleotide Analysis—Osmotic lysis of red blood cells
of sorbitol-synchronized cultures at different stages of the
intraerythrocytic life cycle (rings, trophozoites, and schizonts,
approximately 18, 35, and 44 h postinvasion, respectively) and
10–12% parasitemia was performed by resuspending erythro-
cyte pellet twice in 60 volumes of cold erythrocyte lysis buffer
(10 stock solution: 0.15 M NH4Cl, 0.1 M KHCO3, 0.01 M
EDTA). Non-infected red blood cells were lysed and included
as controls in every analysis to discard noise due to the detec-
tion of sugar nucleotides carried away from the erythrocytes.
The suspension was incubated on ice until lysis was completed
(10 min) (29). Pellets were washed three times with cold
phosphate-buffered saline (PBS), and sugar nucleotide analysis
was performed as described elsewhere (30). Briefly, parasite
pellets were lysed in 70% ethanol in the presence of 20 pmol of
GDP-glucose internal standard, and sugar nucleotides were
extracted using Envi-Carb columns (31). Sugar nucleotides
were then analyzed using LC-MS/MS, using multiple-reaction
monitoring for detection. HPLC conditions were adapted from
Ref. 31, and acetonitrile was added postcolumn to produce sta-
ble electrospray ionization. The peak areas for each sugar
nucleotide, along with their empirically determined molar rel-
ative response factors and the known amount of internal GDP-
glucose, were used to quantify sugar nucleotides. Analyses were
performed on three different sugar nucleotide extracts.
Metabolic Labeling of Parasite with Tritiated Sugars—Para-
site cultures at 10–12% parasitemia were synchronized to the
ring state and then washed and resuspended in RPMI medium
supplemented with Albumax II. Cells were incubated at 3–4%
hematocrit for 16–18 h, until the trophozoite stage. The para-
sites were then washed with glucose-free RPMI supplemented
with Albumax II and 20 mM fructose, and they were metaboli-
cally labeled with 3H-sugars (50 Ci/ml) for 1 or 4 h, adapting
the conditions used in previous work (23, 32, 33). Triplicates of
each condition were included, and controls were “mock-la-
beled” for a few seconds using medium at 4 °C supplemented
with an excess (100-fold) of the unlabeled (cold) sugar. Labeled
cultures and controls were washed three times with PBS at 4 °C
and treated with saponin to release parasites. Free parasites
were washed again three times with PBS at 4 °C and lysed, and
the radioactivity was measured by liquid scintillation counting.
To calculate the amount of sugar incorporated into the gly-
coprotein and glycolipid compartments, after the labeling, free
parasites were further lysed, and the proteins were precipitated
with 10% trichloroacetic acid and filtered (glycoproteins), or
the glycolipids were extracted with organic solvents (glycolip-
ids) (34).
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Expression and Purification of GDP-fucose Biosynthesis
Genes in Escherichia coli—Codon harmonization was used for
the production of heterologously expressed P. falciparum
GDP-mannose 4,6-dehydratase (PfGMD, gene ID PF3D7_
0813800) and GDP-L-fucose synthase (PfFS, gene ID
PF3D7_1014000) in E. coli (35). Codon-harmonized genes
(Genscript) were cloned into the pGEX 6P expression vector
(GEHealthcare) and expressed in BL21 (DE3) E. coli cells. 3-Li-
ter cultures were grown to an A600 nm of 0.6 and induced over-
night at 18 °C with 100 M isopropyl--D-thiogalactopyrano-
side. Cells were harvested and lysed in PBS including 0.1mg/ml
lysozyme in the presence of Complete protease inhibitor mix-
ture (Roche Applied Science). Lysis was ensured by sonication
(Misonix Microson XL 2000). 0.5% Triton X-100 was added,
and, after a 30-min incubation at 4 °C, the lysate was clarified by
centrifugation at 12,000  g for 20 min, and the supernatant
was added to 1 ml of PBS-washed GST beads (GE Healthcare)
and incubated overnight at 4 °C. The beads were collected in
chromatography columns, washed with 10 bead volumes of
PBS before three elutions of 1 ml with 10 mM glutathione in 50
mM Tris-HCl, pH 8. The eluates were pooled, diafiltered with
PBS, and concentrated in 10,000 nominal molecular weight
limit centrifugal filter units (Amicon, Millipore).
GDP-fucose Biosynthesis Assay—Assay conditions were
adapted from elsewhere (36–38). Reactions were performed in
25l (final volume) of 100mMMOPS, pH 7.0, 100mMNaCl, 10
mM dithiothreitol, 5 mM EDTA, 1 mM GDP-mannose (Sigma),
0.4 mMNADPH, and 1 mMNADP. The reaction was started by
adding 1.5 mg/ml of the recombinant PfGMD enzyme, and the
reaction was left to proceed for 3 h at 37 °C. Recombinant PfFS
(1.5 mg/ml) was then added, and the concentration of NADPH
was adjusted to 1.5 mM. For experiments without the PfFS
enzyme, only NADPH was added at this point. Reactions were
stopped after 2 h at 37 °C by heating to 100 °C for 2 min, and
then the samples were filtered to remove insoluble material,
and sugar nucleotides were analyzed by HPLC (31), including
standards for every HPLC series of experiments.
For LC-MS/MS analysis, HPLC conditions were adapted
from Ref. 39, using a porous graphitic carbon column (Hyper-
carb, 100 2.1mm, 5-mparticle size, Thermo Scientific) and
MS-compatible mobile phases. Starting buffer was 0.1% formic
acid, brought to pH 9.0 with ammonia, followed by a 36-min
gradient from 10 to 50% acetonitrile at a flow rate of 100
l/min. Detection was performed by negative mode electros-
pray ionization-MS on an API3000 triple quadrupole
LC-MS/MS mass spectrometer (PE-Sciex) with a declustering
potential of 50 V, focusing potential of 300 V, collision
energy of 30 V, and source temperature of 375 °C.
Cloning and Expression of Epitope-tagged Versions of PfGMD
and PfFS in P. falciparum—Gene PfGMD was amplified from
P. falciparum genomic DNA using primer pARL1F-GMD-
(KpnI) (CGCGGTACCATGCGAGTTGCTTTAATC) and
pARL1R-GMD(PstI) (CGCCTGCAGTTGCTTTTTACCCA-
TTT). PfFS was amplified from P. falciparum cDNA using
primer pARL1F-FS(KpnI) (CGCGGTACCATGACACGAAT-
TTGTCTTGTAACTG) and pARL1R-FS(PstI) (CGCCTG-
CAGTTTTCTTACATTTTTGTATTCGTCAATAAACCA).
P. falciparum genes were cloned in the KpnI-PstI site of trans-
fection vector pARL1a-3HA (40) under the control of the pfcrt
promoter region (41). P. falciparum were transfected as
described previously (41). Briefly, 150 g of each plasmid was
used to electroporate (310 V, 950millifarads) 200l of infected
red blood cells at5% parasitemia, synchronized for ring stage
parasites. Transfected parasites were selected on 2 nM of
WR99210 drug, and resistant parasites appeared in culture
from 25 to 35 days after drug application.
Indirect Immunofluorescence Assays—Cultured P. falcipa-
rum transgenic lines were washed in PBS and then fixed with
4% EM grade paraformaldehyde and 0.075% EM grade glutar-
aldehyde in PBS (42). Fixed cells were permeabilized with 0.1%
TritonX-100 in PBS and blocked for 1 h at room temperature in
3% PBS-bovine serum albumin (PBS-BSA). Samples were incu-
bated overnight with primary antibody (rat anti-HA (1:10;
Roche Applied Science) or rabbit anti-HSP70 (1:50; Stress-
Marq)) (43) diluted in 3% PBS-BSA, followed by a 1-h incuba-
tion with secondary antibody (anti-rat conjugated with Alexa
Fluor 488 or anti-rabbit conjugated with Alexa Fluor 594
(1:200, Invitrogen)) diluted in 3%PBS-BSA.Nucleiwere stained
for 1 h with 4,6-diaminido-2-phenylindole (DAPI; 2 mg/ml
diluted in PBS) during the secondary antibody incubation.Con-
focal microscopy was performed using a laser scanning confo-
cal microscope (TCS-SP5; Leica Microsystems) at the micros-
copy scientific and technical services facility of the Universitat
de Barcelona.
RNA Preparation and Quantitative Real-time PCR—Tight
synchronization of parasites was achieved by Percoll purifica-
tion of schizonts followed by sorbitol lysis 5 h later, to obtain a
population of a defined age window of 0–5 h postinvasion.
RNAwas purified using the TRIzol method at the ring, tropho-
zoite, and schizont stage, and cDNAwas synthesized by reverse
transcription performed using random hexaprimers and
SuperScript-III reverse transcriptase (RT; Invitrogen) accord-
ing to the manufacturer’s instructions and including controls
without RT. All quantitative PCRs were performed using
PowerSYBR Green Master Mix (Invitrogen), and expression
values were calculated using the relative standard curve
method. Results are expressed in arbitrary units, relative to a
genomic DNA standard curve, and were normalized against
seryl-tRNA synthetase (PF3D7_0717700). The primers used
were GGTGATTGCTCAAAGGCAAAA and TTCATAAAC-
GAGCTGGGTAAATGTAT for PfGMD; CTTGTATTTTCC-
CTGTAAATTGTTCTCTAC and GATGGTATAACGTG-
CGCATTTTC for PfFS; TTTTTTAAAGTGATAGACAGG-
GTTAT and AAAAAAGTCCCCTAAATATACATCCT for
PfPoFUT2; and AAGTAGCAGGTCATCGTGGTT and TTC-
GGCACATTCTTCCATAA for seryl-tRNA synthetase.
Preparation of P. falciparum Cell Extracts and [3H]GDP-fu-
cose Incorporation Assays—Percoll-purified infected red blood
cells (36–42 h postinvasion) grown at 10–12% parasitemia
were subjected to saponin lysis and washed three times with
PBS. The cell pellet was placed on ice and homogenized for 1 h
(at 109 cells/ml)with 1%Nonidet P-40, 10mMTris-HCl, pH7.2,
150 mM NaCl, 10 mM MnCl2, 5 mM MgCl2, 1 protease inhib-
itor mixture (Roche Applied Science), 1 mM phenylmethylsul-
fonyl fluoride (PMSF), and 100g/mlN-p-tosyl-L-lysine chlo-
romethyl ketone. Inactivated extracts were boiled for 20 min
Sugar NucleotideMetabolic Routes in P. falciparum
16508 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 23•JUNE 7, 2013
with 3 M urea, 0.1 M dithiothreitol, and 5 mM EDTA. 2 Ci of
[3H]GDP-fucose (American Radiochemical Chemicals, Inc.)
was added to the extract, and the reaction was incubated at
37 °C for 1 h. ProteinswereTCA-precipitated andwashed three
times with cold 100% acetone, and tritium incorporated into
the TCA pellets was measured by scintillation counting.
RESULTS
Sugar Nucleotide Biosynthetic Pathways Predicted in
P. falciparum—Based on the current knowledge of P. falcipa-
rum sugar biochemistry (11, 14, 23, 32) and the predicted met-
abolic pathways (25), we have reconstructed the sugar nucleo-
tide biosynthetic routes present in P. falciparum (Fig. 1). The
enzymes and genes involved in these metabolic routes are
shown in Table 1. Bioinformatic analysis suggests that sugar
nucleotides are made by conventional eukaryotic de novo
routes from glucose 6-phosphate, although other salvage path-
ways also exist (Fig. 1). Conserved pathways for the biosynthesis
of UDP-GlcNAc and GDP-mannose agree well with the mon-
osaccharide content of known P. falciparum glycoconjugates
(i.e.GPI anchors andN-glycans). However, the conservation of
UDP-glucose and GDP-fucose biosynthetic pathways (Fig. 1)
does not correspond with any previous description of fucose
and/or glucose-containing glycans in the parasite. Because
sugar nucleotides are obligate donors for glycosylation reac-
tions mediated by glycosyltransferases, the presence of these
metabolic routes in the parasite genome prompted us to iden-
tify the sugar nucleotide pools present in the blood stages of the
parasite to assess the activation state of these pathways.
Identification and Quantification of Sugar Nucleotide Pools
in P. falciparum Blood Stages—Commercially available sugar
nucleotides were used as standards to identify and quantify the
products of the conserved sugar nucleotidemetabolic pathways
(25) using the 3D7 strain of P. falciparum. Variable levels of
UDP-galactopyranose, UDP-Glc, UDP-GlcNAc, GDP-man-
nose (GDP-Man), and GDP-fucose (GDP-Fuc) pools were
detected through the different blood stages (i.e. rings, tropho-
zoites, and schizonts) of the parasite (Fig. 2 and Table 2). The
sugar nucleotide levels were, in general, 10–100-fold lower
than those of other extracellular protozoan parasites. However,
in the case of GDP-fucose, levels detected were comparable
(Table 2) (30). To exclude the possibility of contamination from
host cell material, non-infected osmotically lysed erythrocyte
ghosts were analyzed and included as negative controls. The
results were at least 1 order of magnitude lower than in the
parasite analysis for every sugar nucleotide (Fig. 2 and Table 2).
The sugar nucleotides detected in the parasite agree well with
the monosaccharide contents of known glycoconjugates in
P. falciparum consisting of glucosamine (derived from
GlcNAc) and Man residues present in GPI anchors and N-gly-
cans (11, 14). Furthermore, the detection of UDP-GlcNAc,
UDP-Glc, GDP-Man, andGDP-Fuc is consistent with the pres-
ence of known or candidate sugar nucleotide biosynthetic
enzymes encoded in the genomeofP. falciparum (25).Wewere
surprised to find that pools of UDP-galactopyranose can be
identified at the different blood stages of the parasites, although
no apparent candidates for UDP-glucose-4-epimerase can be
detected in the genome of the parasite. The possible metabolic
route for the biosynthesis of this sugar nucleotide is discussed
below.
Metabolic Labeling of Parasites with Tritiated Sugars—To
assess the presence of carbohydrate salvage routes in the para-
site P. falciparum-infected erythrocytes, cultures were meta-
bolically labeled with tritiated Man or Fuc in medium contain-
ing 20 mM D-fructose (32, 34, 44, 45). Whereas [3H]Man was
incorporated as described previously (23), [3H]Fuc was not sig-
nificantly taken up by the parasite (Fig. 3A), contributing to less
than 15% of the average pool amount, and we did not detect a
significant incorporation into its glycoproteins or glycolipids
(Fig. 3B). This indicates that the main source of GDP-Fuc for
P. falciparum intraerythrocytic life stages is through the bio-
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FIGURE 1. Sugar nucleotide biosynthetic pathways identified in the genomeof P. falciparum. The numbers refer to the enzymes and known or candidate
genes described in Table 1. Predicted known fates of sugar nucleotide donors according to the glycoconjugates described in P. falciparum are in italic type (or
markedwith aquestionmark if the fate is unknown). Sugar nucleotides identified in this study areboxed.Dotted lines indicate confirmed salvagepathways, and
sugars, taken up from the medium, are underlined. The discontinuous arrow (step 4) represents the glucosamine-phosphate N-acetyltransferase activity (EC
2.3.1.4) for which a candidate gene is not yet identified. HK, hexokinase; G6PI, glucose-6-phosphate isomerase; GFPT, glucosamine-fructose-6-phosphate
aminotransferase; GNA, glucosamine-phosphate N-acetyltransferase; PAGM, phosphoacetylglucosamine mutase; UAP, UDP-N-acetylglucosamine pyrophos-
phorylase; MPI, mannose-1-phosphate isomerase; PMM, phosphomannomutase; MPG, mannose-1-phosphate guanyltransferase; GMD, GDP-mannose 4,6-
dehydratase; FS, GDP-L-fucose synthase; PGM, phosphoglucomutase;UGP, UTP-glucose-1-phosphate uridylyltransferase;GALE, UDP-glucose 4-epimerase;GK,
galactokinase. The suggested pathway for the biosynthesis of UDP-Gal through the activity of the UDP-sugar pyrophosphorylase enzyme is indicated with a
gray discontinuous arrow (see “Discussion”).
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conversion of an existing sugar/sugar nucleotide, which is con-
sistent with the apparent absence of genes encoding enzymes
involved in the GDP-fucose salvage pathway in the P. falcipa-
rum genome (25). Thus, the de novo GDP-Fuc synthetic route
from GDP-Man, which depends on GMD and FS (Fig. 1 and
Table 1), is themost feasible pathway for the biosynthesis of this
sugar nucleotide in P. falciparum.
Similarly, metabolic labeling with [3H]GlcNAc showed that
parasites were unable to take up this sugar from themedia (Fig.
3C). This, together with the labeling of the parasite with
[3H]GlcN, strongly suggests that the sequence of intermediates
in the P. falciparum UDP-GlcNAc biosynthetic pathway is
GlcN6P3 GlcNAc6P3 GlcNAc1P3 UDP-GlcNAc.
P. falciparum GDP-Fuc Biosynthetic Genes Are Active in
Vitro—Both PfGMD and PfFS genes are identified and anno-
tated in the P. falciparum genome (25, 46). The predicted
PfGMD (PF3D7_0813800) protein product is assigned to EC
TABLE 1
Enzymes and genes involved in P. falciparum sugar nucleotide biosynthesis
Step
no.a Enzyme name Enzyme no.
Putative P. falciparum
homologuesb
1 Hexokinase (HK) EC 2.7.1.1 PF3D7_0624000
2 Glucose-6-phosphate isomerase (G6PI) EC 5.3.1.9 PF3D7_1436000c
3 Glucosamine-fructose-6-phosphate aminotransferase (GFPT) EC 2.6.1.16 PF3D7_1025100
4 Glucosamine-phosphate N-acetyltransferase (GNA) EC 2.3.1.4 No gene identifiedd
5 Phosphoacetylglucosamine mutase (PAGM) EC 5.4.2.3 PF3D7_1130000
6 UDP-N-acetylglucosamine pyrophosphorylase (UAP) EC 2.7.7.23 PF3D7_1343600
7 Mannose-6-phosphate isomerase (MPI) EC 5.3.1.8 PF3D7_0801800
8 Phosphomannomutase (PMM) EC 5.4.2.8 PF3D7_1017400
9 Mannose-1-phosphate guanyltransferase (MPG) EC 2.7.7.13 PF3D7_1420900
10 GDP-mannose 4,6-dehydratase (GMD) EC 4.2.1.47 PF3D7_0813800
11 GDP-L-fucose synthase (FS) EC 1.1.1.271 PF3D7_1014000
12 Phosphoglucomutase (PGM) EC 5.4.2.2 PF3D7_1012500
13 UTP-glucose-1-phosphate uridylyltransferase (UGP) or UDP-sugar pyrophosphorylase (USP) EC 2.7.7.9 or EC 2.7.7.64 PF3D7_0517500
14 UDP-glucose 4-epimerase (GALE) EC 5.1.3.2 No gene identified
15 Galactokinase (GK) EC 2.7.1.6 No gene identified
a Step numbers refer to those shown in Fig. 1.
b Gene ID numbers underlined are as identified and annotated in the P. falciparum genome (25, 46), and those in boldface type and underlined have been functionally char-
acterized in this paper.
c Glucose-6-phosphate isomerase (EC 5.3.1.9) enzyme, PF3D7_1436000 has been crystallized, but to our knowledge its activity has not been published (77).
d P. falciparum is thought to process GlcN6P to GlcNAc6P (step 4, Fig. 1) based on the radiolabeling of the parasite with [3H]GlcN (22, 23).
Rings Trophozoites Schizonts Lysed RBCs 
0
0.5
1
1.5
2
2.5
&" '" ("
pm
ol
es
/1
07
 c
el
ls
 
G
D
P
-M
an
 
G
D
P
-F
uc
 
U
D
P
-G
lc
 
U
D
P
-G
al
 
U
D
P
-G
lc
N
A
c 
G
D
P
-M
an
 
G
D
P
-F
uc
 
U
D
P
-G
lc
 
U
D
P
-G
al
 
U
D
P
-G
lc
N
A
c 
G
D
P
-M
an
 
G
D
P
-F
uc
 
U
D
P
-G
lc
 
U
D
P
-G
al
 
U
D
P
-G
lc
N
A
c 
G
D
P
-M
an
 
G
D
P
-F
uc
 
U
D
P
-G
lc
 
U
D
P
-G
al
 
U
D
P
-G
lc
N
A
c 
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
FIGURE 2. Specific sugar nucleotide levels in different blood stages ofP. falciparum.Values of UDP-Glc (open bars), UDP-Gal (black solid bars), UDP-GlcNAc
(striped bars), GDP-Man (dotted bars), and GDP-Fuc (gray solid bars) indicate the average of three different extractions. Error bars, S.D. The last set of bars
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TABLE 2
Sugar nucleotide levels in blood stages of P. falciparum
Sugar
nucleotide
Stage Lysed red
blood cellsa,bRingsa Trophozoitesa Schizontsa
UDP-Glc 0.53 0.12 1.78 0.38 1.96 0.29 0.02
UDP-Gal 0.09 0.04 0.42 0.06 0.61 0.12 0.01
UDP-GlcNAc 0.34 0.04 1.35 0.26 1.31 0.11 0.02
GDP-Man 0.31 0.06 0.69 0.08 0.74 0.06 0.01
GDP-Fuc 0.27 0.01 0.53 0.02 0.17 0.02 0.01
a Amounts are indicated in pmol/107 cells.
b S.D. values are at least 1 order of magnitude smaller than the calculated amount
and are not included.
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4.2.1.47 and presents 48.1% sequence identity and 61.4% simi-
larity to its human counterpart. PfFS (PF3D7_1014000)
encodes a protein assigned to EC 1.1.1.271 that has a 35.7%
sequence identity and 57.1% similarity to its human homolog.
The presence of putative PfGMD and PfFS genes, together
with the detection of GDP-Fuc in P. falciparum intraerythro-
cytic stages, suggests that the protein products of these genes
would be active GDP-Fuc biosynthetic enzymes. To assess this,
we expressed both PfGMD and PfFS genes in E. coli with the
addition ofN-terminalGST tags. In both cases, soluble proteins
could be purified by GST affinity chromatography (Fig. 4A).
The enzymes were assayed as described under “Experimental
Procedures,” and the sugar nucleotides produced were ana-
lyzed either by LC-MS/MSor by reverse phase ion pairing chro-
matography. When both enzymes were added to the reaction,
GDP-Fuc was readily detected (Fig. 4B, top panels). Both
enzymes are required for the production of GDP-Fuc, because
in the presence of PfFS only, there was no turnover of GDP-
Man (not shown), and with only PfGMD, a novel GDP-deoxy-
hexose with a different retention time was generated (Fig. 4B,
middle panels). The production of a novel GDP-deoxyhexose
by a GMD enzyme in the absence of an FS enzyme has been
reported before (36, 47). In addition, in the presence of PfGMD
alone, we detected also a product at 586 m/z, which coincides
with the molecular weight of GDP-4-keto-6-deoxy mannose.
Although there are no commercial standards available to ana-
lyze the transition of GDP-4-keto-6-deoxy mannose for identi-
fication, the fragmentation of this novel product produced a
major product ion at m/z 442 corresponding to a [GDP-H],
strongly resembling the fragmentation of GDP-deoxyhexoses
(Fig. 4B, bottom panels) (30, 36).
To assess the effect of time and GDP-Man and PfGMD/PfFS
concentration on the production of GDP-Fuc, we performed
different activity assays where sugar nucleotides were meas-
ured by reverse phase HPLC. GDP-Fuc production was
dependent on time and the initial concentration of GDP-Man
(Fig. 4C). Interestingly, at the PfGMD and GDP-Man concen-
trations tested (1.5mg/ml and 1mM, respectively), PfFS did not
become rate-limiting at 1mg/ml, whereas decreasing the initial
concentration of PfGMD to 1 mg/ml reduced the relative yield
of GDP-Fuc to a 70%.
PfGMD and PfFS Are Expressed during P. falciparum Intra-
erythrocytic Life Cycle and Their Protein Products Localize in
the Cytosol of the Parasite—Real-time quantitative RT-PCR
analysis of PfGMD and PfFS RNA transcripts was performed at
the different asexual stages of P. falciparum (rings, trophozo-
ites, and schizonts), and expression values were calculated
using the relative standard curve method. In both cases, the
highest expression levels were found at the schizont phase (Fig.
5), in agreement with what had been observed previously in
other studies and with what is annotated in P. falciparummet-
abolic databases (25, 48, 49).Nevertheless, transcription of both
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genes through the whole intraerythrocytic cycle is 10-fold
lower than that of the seryl-tRNA synthetase housekeeping
gene expression taken as a reference (48), withmuch lowerPfFS
levels in the ring stage (Fig. 5).
To assess the subcellular location of PfGMD and PfFS pro-
teins, HA-tagged versions of the genes were transiently
expressed under the control of the crt promoter using the
pARL1a-3HA expression vector (41). Immunofluorescence
microscopy using anti-HA antibodies produced a typical cyto-
solic distribution in the different stages of the intraerythrocytic
life cycle (Fig. 6). To confirm this, we also stained the cells using
anti-HSP70 antibody, a commonly used cytosolic marker (43).
The merged image shows co-localization, indicating that the
expressed HA-tagged PfGMD and PfFS are localized in the
cytosol of P. falciparum through the different stages of the par-
asite asexual life cycle.
P. falciparum Schizonts Express a Protein o-Fucosyltrans-
ferase (PoFUT2) Homolog and Incorporate [3H]GDP-Fuc in a
Cell-free Assay—The P. falciparum genome presents a homo-
log of PoFUT2 that, in other organisms, is involved in theO-fu-
cosylation of thrombospondin type 1 repeat (TSR) domains
(50). Because this gene (PF3D7_0909200) is the most suitable
candidate to encode for a fucosyltransferase activity, we per-
formed real-time quantitative RT-PCR analysis of PfPoFUT2 at
the different blood stages of P. falciparum. Despite the low lev-
els, a peak of expression was observed at the schizont phase of
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the parasite (Fig. 7A) coinciding with the maximum expression
ofPfGMD andPfFS genes. Furthermore,P. falciparum schizont
extracts incorporated [3H]GDP-Fuc, strongly suggesting that
fucosylation processes are active in the late stages of the asexual
life cycle of the parasite (Fig. 7B).
DISCUSSION
Carbohydrate structures that decorate the surface of cells
play important roles in the biology of host-pathogen interac-
tions. In the particular case of themalaria parasite, glycan struc-
tures associated with the parasite itself appear to be limited to
GPI anchors (11, 51) and the recently describedN-glycans (14).
This seems to confirm the general trend of Plasmodium para-
sites to reduce severalmetabolic and biosynthetic pathways and
reflects the process of evolving toward a parasitic niche (52).
However, the parasite genome encodes orthologues for
enzymes involved in the biosynthesis of sugar nucleotides not
related to GPI anchor or N-glycan structures, which prompted
us to survey the sugar nucleotide pools present in the asexual
life stages of P. falciparum. Qualitatively, the sugar nucleotide
content of P. falciparum obtained by LC-electrospray ioniza-
tion-MS/MS agrees well with the presence of known or candi-
date sugar nucleotide biosynthesis enzymes (Fig. 1) (25), with
the exception of the presence of a significant pool of UDP-Gal
(see below). Quantitatively, the sugar nucleotide amounts
observed are consistent with the increasedmetabolic activity of
mature stage parasites (53, 54). The analysis performed,
together with the information available in annotated P. falcip-
arummetabolic databases (25), enabled us to thoroughly verify
the presence of active sugar nucleotidemetabolic routes during
the parasite blood stages and, in some cases, add new evidence
to support the annotations of genes likely to be involved in
sugar nucleotide biosynthesis. The presence and conservation
of these sugar nucleotide metabolic pathways in several Plas-
modium genomes (46), togetherwith the detection of their final
products, are strong arguments to presume the existence of
further downstream reactions in which these metabolites are
involved and expose new active metabolic pathways accessible
for the exploration of their biological function.
The identification of UDP-Gal is somewhat puzzling. The
P. falciparum genome lacks candidate genes for a UDP-glucose
4-epimerase (EC 5.1.3.2) that can produce UDP-galactose via
the epimerization of UDP-glucose or a galactose-1-phosphate
uridylyl transferase activity (EC 2.7.7.12) (25). Thus, two main
activities can be proposed for the production of this sugar
nucleotide. Either an enzyme with UTP-glucose-1-phosphate
uridylyltransferase activity (EC 2.7.7.9) presents a weak galac-
tose-1-phosphate uridylyltransferase activity (EC 2.7.7.10), as
described in mammals (55, 56), or a broad substrate range
UDP-sugar pyrophosphorylase (EC 2.7.7.64) is present in the
genome of P. falciparum, as described in plants or Leishmania
major (57–61). UDP-sugar pyrophosphorylase is an enzyme
that can nonspecifically utilize UTP and glucose 1-phosphate
or galactose 1-phosphate to produce UDP-glucose or UDP-ga-
lactose and pyrophosphate. Interestingly, searches with func-
tionally characterized UDP-sugar pyrophosphorylase ortho-
logues from plants and L. major identify a match,
PF3D7_0517500, with more than 30% similarity and an e value
of1055. However, although galactose competes for P. falcip-
arum PfHT1 hexose permease (45) and its incorporation into
the parasite galactolipids has been reported (62, 63), there is not
a clear galactokinase candidate in the P. falciparum genome,
and tritiated galactose is not significantly incorporated into the
parasite proteins (23) or into the -galactose moieties of
digalactosyl diglycerides (64).
Bioinformatic analysis (25) and our own work suggest that
UDP-GlcNAc, the direct donor for all GlcNAc transferases, is
made in P. falciparum by the conventional eukaryotic de novo
route from glucose 6-phosphate (Fig. 1), although a salvage
pathway also exists, via the action of hexokinase (GlcN 3
GlcN-6-P) (22, 23).Withmore than 30% similarity and e values
of1020 to plant and humanUDP-GlcNAc diphosphorylases
(EC 2.7.7.23), PF3D7_1343600 is the most suitable candidate
gene to encode this activity in the P. falciparum genome (Fig. 1
and Table 1), although redundant activity from PF3D7_
0517500 might be expected. The lack of a candidate for a gene
encoding for UDP-glucose 4-epimerase (EC 5.1.3.2) that could
present a UDP-GlcNAc 4-epimerase activity (EC 5.1.3.7) to
convert UDP-GlcNAc into UDP-GalNAc indicates that the
parasite probably does not produce UDP-N-acetyl galactos-
amine, in agreement with the inability of the parasite to syn-
thesize GalNAc and the absence of mucin-type O-glycosyla-
tion in P. falciparum (63, 65).
The main question regarding the UDP-GlcNAc biosynthetic
pathway is the identity of a gene encoding for the glucosamine-
phosphate N-acetyltransferase activity (EC 2.3.1.4 (25)). The
identification of pools of UDP-GlcNAc in the parasite (Fig. 2),
PfGMD-HA 
DIC DAPI Anti-HA Anti-PfHSP70 Merge 
PfFS-HA 
FIGURE 6. Subcellular localization of PfGMD and PfFS expressed in P. falciparum. PfGMD-HA-expressing and PfFS-HA-expressing trophozoites were
labeledwith anti-HA (green), anti-PfHSP70 (red), andDAPI for nuclear staining (blue). The first column represents the differential interference contrast (DIC), and
last column represents themerge of HA and PfHSP70 signals. Similar co-localizationwas observed in other stages of the intraerythrocytic life cycle (not shown).
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alongwith the labeling ofGPI-anchored proteins using tritiated
glucosamine (Fig. 3C) (23, 63), strongly suggests that the
UDP-GlcNAcmetabolic route (25) (Fig. 1) is active in P. falcip-
arum. Most likely the UDP-GlcNAc de novo pathway from glu-
cose is the most important in vivo for the parasite, because
glucosamine is not an abundant free sugar in themammalian or
insect host. Because the glucosamine moiety, derived from
GlcNAc by de-N-acetylation (27), is present in GPI structures
that serve as membrane anchors for many important surface
antigens of the parasite invasive stages (12, 66), the inability to
identify a candidate gene encoding for the glucosamine-phos-
phate N-acetyltransferase activity is very intriguing because
this pathway is potentially targetable for selective anti-malarial
drug design.
The presence of the fucose donorGDP-Fuc in the intraeryth-
rocytic stages of P. falciparum is not surprising, because the
parasite contains homologues of the enzymes involved in the
biosynthesis of this precursor fromGDP-Man.We have shown
that PfGMD and PfFS are active in vitro (Fig. 4), and they are
expressed through the parasite’s asexual life cycle (Fig. 5) (67).
The GDP-Fuc pools in P. falciparum are, on average (Table 2),
comparablewith the pools of other protozoan parasites, such as
trypanosomatids (30), including T. brucei, for which this
metabolite is essential (36). The apparent lack of agreement
with the amount of the GDP-Fuc pool in the schizont stage of
the parasite when the PfFS gene is more expressed may be due
to the specific demand of the metabolite at that stage. Because
sugar nucleotides are donors for glycosylation reactions, the
rates of turnover and the amount of the pools detected may
change, reflecting their utilization. The localization of both
enzymes in the cytoplasmic compartment (Fig. 6), as aldolase
and other enzymes involved in the metabolism of carbohy-
drates (68), agrees well with the identification of a putative
GDP-Fuc transporter in the P. falciparum endoplasmic reticu-
lum/Golgi apparatus (69), where N- and O-glycosylation pro-
cesses occur. The location and function of a putative fucose-
containing glycan in P. falciparum remain enigmatic, and
biosynthetic labeling with tritiated fucose is not feasible,
because there is no prominent GDP-Fuc salvage pathway in the
parasite, and/or hexose transporters do not efficiently take up
fucose (Fig. 3). However, the labeling of parasite extracts after
incubation with modified precursors opens a door to the iden-
tification of putative fucose-containing glycoconjugates (Fig.
7B). Interestingly, the C-terminal region of P. falciparum cir-
cumsporozoite surface protein (CS), in which the RTS,S
malaria vaccine is based (70), and other proteins of the parasite
(71) contain TSR domains. TSR domains are generallyO-fuco-
sylated in higher eukaryotes by PoFUT2, and the fucose residue
can be further modified by the addition of 1–3 glucose (72–
74). The C-terminal region of CS, containing the TSR domain,
was recently expressed in HEK293T cells and structurally ana-
lyzed, showing the presence of a fucose and a glucose residue
(75, 76). The expression of PoFUT2 in P. falciparum (Fig. 7A)
and its conservation in other Plasmodium species raise the pos-
sibility of the presence of a mechanism ofO-fucosylation of CS
and other TSR-containing proteins in the parasite.
In summary, in this work, we have reported the first evidence
of the presence of sugar nucleotides in the blood stages of P. fal-
ciparum, and we have described the active metabolic routes
involved in their biosynthesis. In addition, we have character-
ized the de novo route of GDP-Fuc, ametabolite thatmay prob-
ably be involved in the biosynthesis of novel fucosylated glycans
not yet described in the malaria parasite.
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